Selected research
Industry Research
Pharma Grade Polyvinylpyrrolidone Industry Research Report 2026
Market perspective
The global Pharma Grade Polyvinylpyrrolidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharma Grade Polyvinylpyrrolidone is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharma Grade Polyvinylpyrrolidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharma Grade Polyvinylpyrrolidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharma Grade Polyvinylpyrrolidone include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharma Grade Polyvinylpyrrolidone market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Pharma Grade Polyvinylpyrrolidone.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma Grade Polyvinylpyrrolidone Market by Company
BASF
Ashland
Boai NKY Medical Holdings
JH Nanhang Life Sciences
Chongqing Star-Tech Specialty Products
Huangshan Bonsun Pharmaceuticals
Shanghai Yuking Water Soluble Material Tech
Shanghai Qifuqing Material Technology
Jiaozuo Zhongwei Special Products Pharmaceutical
CNSIG Anhui Hongsifang Fertilizer
Pharma Grade Polyvinylpyrrolidone Segment by Type
K17
K25
K30
K90
Other
Pharma Grade Polyvinylpyrrolidone Segment by Application
Oral Preparations
Injectable Preparations
Topical Preparations
Others
Pharma Grade Polyvinylpyrrolidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Grade Polyvinylpyrrolidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Grade Polyvinylpyrrolidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Grade Polyvinylpyrrolidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharma Grade Polyvinylpyrrolidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharma Grade Polyvinylpyrrolidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharma Grade Polyvinylpyrrolidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- K17
- K25
- K30
- K90
- Other
Applications
- Oral Preparations
- Injectable Preparations
- Topical Preparations
- Others
Companies covered
- BASF
- Ashland
- Boai NKY Medical Holdings
- JH Nanhang Life Sciences
- Chongqing Star-Tech Specialty Products
- Huangshan Bonsun Pharmaceuticals
- Shanghai Yuking Water Soluble Material Tech
- Shanghai Qifuqing Material Technology
- Jiaozuo Zhongwei Special Products Pharmaceutical
- CNSIG Anhui Hongsifang Fertilizer
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharma Grade Polyvinylpyrrolidone by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 K17
- 2.2.3 K25
- 2.2.4 K30
- 2.2.5 K90
- 2.2.6 Other
- 2.3 Pharma Grade Polyvinylpyrrolidone by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Preparations
- 2.3.3 Injectable Preparations
- 2.3.4 Topical Preparations
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Pharma Grade Polyvinylpyrrolidone Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Pharma Grade Polyvinylpyrrolidone Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Pharma Grade Polyvinylpyrrolidone Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Pharma Grade Polyvinylpyrrolidone Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharma Grade Polyvinylpyrrolidone Production by Manufacturers (2021-2026)
- 3.2 Global Pharma Grade Polyvinylpyrrolidone Production Value by Manufacturers (2021-2026)
- 3.3 Global Pharma Grade Polyvinylpyrrolidone Average Price by Manufacturers (2021-2026)
- 3.4 Global Pharma Grade Polyvinylpyrrolidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma Grade Polyvinylpyrrolidone Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Pharma Grade Polyvinylpyrrolidone Manufacturers, Product Type & Application
- 3.7 Global Pharma Grade Polyvinylpyrrolidone Manufacturers Established Date
- 3.8 Global Pharma Grade Polyvinylpyrrolidone Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BASF
- 4.1.1 BASF Pharma Grade Polyvinylpyrrolidone Company Information
- 4.1.2 BASF Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.1.3 BASF Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 BASF Product Portfolio
- 4.1.5 BASF Recent Developments
- 4.2 Ashland
- 4.2.1 Ashland Pharma Grade Polyvinylpyrrolidone Company Information
- 4.2.2 Ashland Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.2.3 Ashland Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Ashland Product Portfolio
- 4.2.5 Ashland Recent Developments
- 4.3 Boai NKY Medical Holdings
- 4.3.1 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Company Information
- 4.3.2 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.3.3 Boai NKY Medical Holdings Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Boai NKY Medical Holdings Product Portfolio
- 4.3.5 Boai NKY Medical Holdings Recent Developments
- 4.4 JH Nanhang Life Sciences
- 4.4.1 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Company Information
- 4.4.2 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.4.3 JH Nanhang Life Sciences Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 JH Nanhang Life Sciences Product Portfolio
- 4.4.5 JH Nanhang Life Sciences Recent Developments
- 4.5 Chongqing Star-Tech Specialty Products
- 4.5.1 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Company Information
- 4.5.2 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.5.3 Chongqing Star-Tech Specialty Products Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Chongqing Star-Tech Specialty Products Product Portfolio
- 4.5.5 Chongqing Star-Tech Specialty Products Recent Developments
- 4.6 Huangshan Bonsun Pharmaceuticals
- 4.6.1 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Company Information
- 4.6.2 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.6.3 Huangshan Bonsun Pharmaceuticals Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Huangshan Bonsun Pharmaceuticals Product Portfolio
- 4.6.5 Huangshan Bonsun Pharmaceuticals Recent Developments
- 4.7 Shanghai Yuking Water Soluble Material Tech
- 4.7.1 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Company Information
- 4.7.2 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.7.3 Shanghai Yuking Water Soluble Material Tech Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Shanghai Yuking Water Soluble Material Tech Product Portfolio
- 4.7.5 Shanghai Yuking Water Soluble Material Tech Recent Developments
- 4.8 Shanghai Qifuqing Material Technology
- 4.8.1 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Company Information
- 4.8.2 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.8.3 Shanghai Qifuqing Material Technology Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Shanghai Qifuqing Material Technology Product Portfolio
- 4.8.5 Shanghai Qifuqing Material Technology Recent Developments
- 4.9 Jiaozuo Zhongwei Special Products Pharmaceutical
- 4.9.1 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Company Information
- 4.9.2 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.9.3 Jiaozuo Zhongwei Special Products Pharmaceutical Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Jiaozuo Zhongwei Special Products Pharmaceutical Product Portfolio
- 4.9.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
- 4.10 CNSIG Anhui Hongsifang Fertilizer
- 4.10.1 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Company Information
- 4.10.2 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Business Overview
- 4.10.3 CNSIG Anhui Hongsifang Fertilizer Pharma Grade Polyvinylpyrrolidone Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 CNSIG Anhui Hongsifang Fertilizer Product Portfolio
- 4.10.5 CNSIG Anhui Hongsifang Fertilizer Recent Developments
5 Global Pharma Grade Polyvinylpyrrolidone Production by Region
- 5.1 Global Pharma Grade Polyvinylpyrrolidone Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharma Grade Polyvinylpyrrolidone Production by Region: 2021-2032
- 5.2.1 Global Pharma Grade Polyvinylpyrrolidone Production by Region: 2021-2026
- 5.2.2 Global Pharma Grade Polyvinylpyrrolidone Production Forecast by Region (2027-2032)
- 5.3 Global Pharma Grade Polyvinylpyrrolidone Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Pharma Grade Polyvinylpyrrolidone Production Value by Region: 2021-2032
- 5.4.1 Global Pharma Grade Polyvinylpyrrolidone Production Value by Region: 2021-2026
- 5.4.2 Global Pharma Grade Polyvinylpyrrolidone Production Value Forecast by Region (2027-2032)
- 5.5 Global Pharma Grade Polyvinylpyrrolidone Market Price Analysis by Region (2021-2026)
- 5.6 Global Pharma Grade Polyvinylpyrrolidone Production and Value, YOY Growth
- 5.6.1 North America Pharma Grade Polyvinylpyrrolidone Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Pharma Grade Polyvinylpyrrolidone Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Pharma Grade Polyvinylpyrrolidone Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Pharma Grade Polyvinylpyrrolidone Production Value Estimates and Forecasts (2021-2032)
6 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region
- 6.1 Global Pharma Grade Polyvinylpyrrolidone Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region (2021-2032)
- 6.2.1 Global Pharma Grade Polyvinylpyrrolidone Consumption by Region: 2021-2026
- 6.2.2 Global Pharma Grade Polyvinylpyrrolidone Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Pharma Grade Polyvinylpyrrolidone Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Pharma Grade Polyvinylpyrrolidone Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Pharma Grade Polyvinylpyrrolidone Production by Type (2021-2032)
- 7.1.1 Global Pharma Grade Polyvinylpyrrolidone Production by Type (2021-2032) & (t)
- 7.1.2 Global Pharma Grade Polyvinylpyrrolidone Production Market Share by Type (2021-2032)
- 7.2 Global Pharma Grade Polyvinylpyrrolidone Production Value by Type (2021-2032)
- 7.2.1 Global Pharma Grade Polyvinylpyrrolidone Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Pharma Grade Polyvinylpyrrolidone Production Value Market Share by Type (2021-2032)
- 7.3 Global Pharma Grade Polyvinylpyrrolidone Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Pharma Grade Polyvinylpyrrolidone Production by Application (2021-2032)
- 8.1.1 Global Pharma Grade Polyvinylpyrrolidone Production by Application (2021-2032) & (t)
- 8.1.2 Global Pharma Grade Polyvinylpyrrolidone Production Market Share by Application (2021-2032)
- 8.2 Global Pharma Grade Polyvinylpyrrolidone Production Value by Application (2021-2032)
- 8.2.1 Global Pharma Grade Polyvinylpyrrolidone Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Pharma Grade Polyvinylpyrrolidone Production Value Market Share by Application (2021-2032)
- 8.3 Global Pharma Grade Polyvinylpyrrolidone Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Pharma Grade Polyvinylpyrrolidone Value Chain Analysis
- 9.1.1 Pharma Grade Polyvinylpyrrolidone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Pharma Grade Polyvinylpyrrolidone Production Mode & Process
- 9.2 Pharma Grade Polyvinylpyrrolidone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharma Grade Polyvinylpyrrolidone Distributors
- 9.2.3 Pharma Grade Polyvinylpyrrolidone Customers
10 Global Pharma Grade Polyvinylpyrrolidone Analyzing Market Dynamics
- 10.1 Pharma Grade Polyvinylpyrrolidone Industry Trends
- 10.2 Pharma Grade Polyvinylpyrrolidone Industry Drivers
- 10.3 Pharma Grade Polyvinylpyrrolidone Industry Opportunities and Challenges
- 10.4 Pharma Grade Polyvinylpyrrolidone Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst